
From Student to AML Patient in Days, Maddie’s Story Shows Why Trials Matter
After relapsing with leukaemia, Maddie aged 24, was out of options—except for one. A clinical trial gave her hope.
Every single penny raised and donated to Cure Leukaemia goes straight back into funding clinical trials and research, through the Trials and Acceleration Programme (TAP).
The aim of these clinical trials is to not only find better, more effective, and kinder treatments for leukaemia, but it also connect patients to potentially life-saving treatments.
With donations and funding, clinical trials can work to create better treatment for blood cancer patients.
In the UK, someone is diagnosed with blood cancer every 14 minutes.
There are currently 250,000 people living with blood cancer in the UK.
There’s plenty of other ways to get involved and help – from fundraising on your own, to taking part in one of our events.
After relapsing with leukaemia, Maddie aged 24, was out of options—except for one. A clinical trial gave her hope.
Diary of Sara, an Acute Lymphoblastic Leukaemia (ALL) Patient.
On World Blood Cancer Day, we stand in solidarity with patients, families, researchers, and healthcare professionals who are fighting to change that.
After living cancer-free for 15 years, Rob faced two devastating relapses of stage 4 lymphoma. The thought of enduring another six months of chemotherapy was overwhelming — until he was offered a place on the ZUMA-22 clinical trial, exploring the use of CAR-T cell therapy for relapsed lymphoma patients.